Table 7

Response characteristics results

nEvaluatedCRPRNot evaluatedaCR + PR
44408 (20%)11 (28%)419 (48%)
Response duration (median, 7 months)
CR 26+, 22, 15,b 8,b 7, 7,b 6,b 3b
PR 14,b 10, 8,b 7,b 4, 4, 3, 2,b 2,b 2, 2b
  • a Two patients were lost to follow-up and two with ocular primary tumor were excluded.

  • b CNS initial site of relapse in 11 responding patients.